News
UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390. Rice shared his views ...
2d
Zacks.com on MSNCVS or Cigna: Which Diversified Healthcare Stock Should You Own Now?CVS rallies on turnaround momentum and EPS growth, while CI is a defensive play with stable returns and a focused healthcare ...
Express Scripts and CVS Pharmacy — two of the three biggest U.S. pharmacy benefit managers — are suing to block an Arkansas ...
Express Scripts by Evernorth, the pharmacy benefits business of The Cigna Group, and its affiliated pharmacies, filed a ...
The two companies contend the state law will force many pharmacies to close, reducing patient access and increasing costs.
Sheldon Ekirch spends a lot of time on hold with her health insurance company. Sometimes, as the minutes tick by and her ...
The rise of new challengers is placing new pressure on publicly traded incumbents, which are deeply embedded in the traditional layers of healthcare.
A lawsuit was filed in Little Rock federal court on Thursday to overturn an Arkansas law preventing pharmacy benefit managers ...
Officials urge St. Louis’ corporate community to help shoulder the cost of housing for the hundreds of residents who have been displaced by the May 16 tornado.
Blue Cross plans are retreating from GLP-1 weight-loss drug coverage after spending hundreds of millions of dollars on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results